Twin Tree Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $697K | Sell |
8,700
-111,000
| -93% | -$9.15M | 0.01% | 848 |
|
|
2025
Q4 | $10.2M | Buy |
119,700
+31,900
| +36% | +$2.62M | 0.09% | 283 |
|
|
2025
Q3 | $6.83M | Buy |
87,800
+31,300
| +55% | +$2.45M | 0.03% | 644 |
|
|
2025
Q2 | $4.42M | Sell |
56,500
-172,200
| -75% | -$12.8M | 0.01% | 1041 |
|
|
2025
Q1 | $16.6M | Buy |
228,700
+218,500
| +2,142% | +$15.6M | 0.03% | 503 |
|
|
2024
Q4 | $755K | Sell |
10,200
-41,200
| -80% | -$2.88M | ﹤0.01% | 1303 |
|
|
2024
Q3 | $3.39M | Sell |
51,400
-120,200
| -70% | -$8.73M | 0.01% | 1018 |
|
|
2024
Q2 | $15.9M | Sell |
171,600
-71,100
| -29% | -$6.3M | 0.04% | 438 |
|
|
2024
Q1 | $23.2M | Buy |
+242,700
| New | +$20.4M | 0.05% | 367 |
|
|
2023
Q4 | – | Sell |
-41,800
| Closed | -$2.9M | – | 1423 |
|
|
2023
Q3 | $2.9M | Hold |
41,800
| – | – | 0.01% | 801 |
|
|
2023
Q2 | $3.94M | Buy |
+41,800
| New | +$3.63M | 0.01% | 815 |
|
|
2023
Q1 | – | Sell |
-70,600
| Closed | -$5.27M | – | 1371 |
|
|
2022
Q4 | $5.27M | Sell |
70,600
-150,100
| -68% | -$11.6M | 0.01% | 732 |
|
|
2022
Q3 | $18.2M | Sell |
220,700
-415,200
| -65% | -$40M | 0.03% | 384 |
|
|
2022
Q2 | $60.5M | Buy |
635,900
+207,900
| +49% | +$21.5M | 0.1% | 144 |
|
|
2022
Q1 | $50.4M | Buy |
428,000
+261,000
| +156% | +$29.3M | 0.08% | 188 |
|
|
2021
Q4 | $21.6M | Buy |
167,000
+149,900
| +877% | +$17.5M | 0.05% | 381 |
|
|
2021
Q3 | $1.94M | Sell |
17,100
-58,500
| -77% | -$6.68M | ﹤0.01% | 1038 |
|
|
2021
Q2 | $7.83M | Buy |
75,600
+48,100
| +175% | +$4.53M | 0.02% | 574 |
|
|
2021
Q1 | $2.3M | Sell |
27,500
-82,800
| -75% | -$7M | 0.01% | 817 |
|
|
2020
Q4 | $10.1M | Buy |
+110,300
| New | +$9.15M | 0.04% | 441 |
|
|
2020
Q3 | – | Sell |
-239,400
| Closed | -$16.5M | – | 1335 |
|
|
2020
Q2 | $16.5M | Buy |
+239,400
| New | +$17M | 0.07% | 318 |
|
|
2019
Q4 | – | Sell |
-320,100
| Closed | -$23.5M | – | 1284 |
|
|
2019
Q3 | $23.5M | Sell |
320,100
-22,500
| -7% | -$1.58M | 0.09% | 165 |
|
|
2019
Q2 | $21.1M | Sell |
342,600
-368,400
| -52% | -$22.3M | 0.1% | 175 |
|
|
2019
Q1 | $45.3M | Buy |
711,000
+628,200
| +759% | +$35.9M | 0.24% | 84 |
|
|
2018
Q4 | $4.23M | Sell |
82,800
-103,500
| -56% | -$5.24M | 0.03% | 534 |
|
|
2018
Q3 | $10.8M | Buy |
+186,300
| New | +$9.11M | 0.07% | 240 |
|
|
2018
Q2 | – | Sell |
-165,900
| Closed | -$7.71M | – | 1190 |
|
|
2018
Q1 | $7.71M | Buy |
165,900
+142,500
| +609% | +$6.19M | 0.06% | 256 |
|
|
2017
Q4 | $879K | Sell |
23,400
-25,200
| -52% | -$925K | 0.01% | 733 |
|
|
2017
Q3 | $1.77M | Buy |
48,600
+42,300
| +671% | +$1.61M | 0.01% | 589 |
|
|
2017
Q2 | $248K | Buy |
+6,300
| New | +$230K | ﹤0.01% | 802 |
|
|
2016
Q3 | – | Sell |
-28,200
| Closed | -$937K | – | 1200 |
|
|
2016
Q2 | $937K | Buy |
28,200
+18,600
| +194% | +$636K | 0.01% | 683 |
|
|
2016
Q1 | $282K | Buy |
+9,600
| New | +$265K | 0.01% | 940 |
|
|
2015
Q4 | – | Sell |
-114,600
| Closed | -$2.71M | – | 1440 |
|
|
2015
Q3 | $2.71M | Buy |
114,600
+58,800
| +105% | +$1.42M | 0.07% | 272 |
|
|
2015
Q2 | $1.32M | Sell |
55,800
-134,400
| -71% | -$3.03M | 0.03% | 537 |
|
|
2015
Q1 | $4.52M | Sell |
190,200
-99,000
| -34% | -$2.22M | 0.12% | 196 |
|
|
2014
Q4 | $6.14M | Buy |
289,200
+157,800
| +120% | +$3.17M | 0.17% | 122 |
|
|
2014
Q3 | $2.24M | Buy |
+131,400
| New | +$2.07M | 0.06% | 349 |
|
|
2013
Q3 | – | Sell |
-64,800
| Closed | -$726K | – | 840 |
|
|
2013
Q2 | $726K | Buy |
+64,800
| New | +$767K | 0.03% | 530 |
|
Other funds holding EW
VCM
VPM
Twin Tree Management's EW Position: Q2 2025 in Review
Twin Tree Management sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 94,106 shares — an estimated $7.02M sold.
Twin Tree Management first reported a position in EW in Q2 2013 and held it in 35 quarters. The position peaked at $40.9M in Q2 2022. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2025.
- Twin Tree Management reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
- Twin Tree Management sold 94,106 Edwards Lifesciences shares in Q2 2025, an estimated $7.02M.
- Twin Tree Management first reported a position in Edwards Lifesciences in Q2 2013 and held it in 35 quarters.
- Twin Tree Management's Edwards Lifesciences position peaked at $40.9M in Q2 2022.
- 1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.
Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.